Clinical Trial Update: Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and efficacy of intravenous TZP-101 in patients with diabetic gastroparesis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Gastroparesis

Drugs mentioned

• TZP-101

Snippet

Sponsor: Tranzyme, Inc. | Conditions: Gastroparesis, Diabetes Mellitus | Phase 1 | Status: COMPLETED